Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 10Liver Neoplasms 8Neoplasm Metastasis 6Colorectal Neoplasms 6Melanoma 4Esophageal Neoplasms 4Sarcoma 3Prostatic Neoplasms 3Colonic Neoplasms 3Cholangiocarcinoma 3Carcinoma, Renal Cell 3Rectal Neoplasms 2Pancreatic Neoplasms 2Osteosarcoma 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Biliary Tract Neoplasms 2Barrett Esophagus 2Wilms Tumor 1Uveal Melanoma 1Unresectable Pancreatic Cancer 1Tongue Neoplasms 1Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Salivary Gland Neoplasms 1Rhabdomyosarcoma 1Pancreatic Adenocarcinoma Locally Advanced 1Pain 1

Interventions

Electroporation 2monomethyl auristatin E 1Oxaliplatin 1Gemcitabine 1Cryosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unresectable Pancreatic Cancer × Cryosurgery × Gastrointestinal × Clear all
NCT03239184 2019-01-25

Bioinformation Therapy for Pancreatic Cancer

Fuda Cancer Hospital, Guangzhou

Phase 2/3 Completed
120 enrolled
Gastrointestinal

Unresectable Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡